SMMT — Summit Therapeutics Inc. | XLV Holdings | StockAdder

(SMMT)

Summit Therapeutics Inc.

Live chart and latest SMMT stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

SMMT News

What makes Summit Therapeutics (SMMT) one of the best large caps under $30

Apr 11, 2026 Stock Traders Daily

How Summit Therapeutics Inc. (SMMT) Affects Rotational Strategy Timing

Apr 14, 2026 Yahoo Finance

Is Summit Therapeutics Inc. (SMMT) One of the Most Oversold NASDAQ Stocks to Invest In?

Feb 12, 2026 Stock Titan

Summit Therapeutics (SMMT) asks shareholders to approve 8M-share Plan increase

Apr 6, 2026 Benzinga

What's Going On With Summit Therapeutics Stock Wednesday? - Summit Therapeutics (NASDAQ:SMMT)

Apr 8, 2026 Yahoo Finance

Summit Therapeutics (SMMT) Grabs Investor Attention After Major FDA Breakthrough

Feb 16, 2026 Stock Titan

Summit lung cancer drug showed 10.1-month brain PFS in Phase III

Mar 27, 2026 Yahoo Finance

Summit Therapeutics (SMMT) Ends 2025 With Strong Cash Reserves and Increased Clinical Investment

Mar 2, 2026 Yahoo Finance

Summit Therapeutics (SMMT) Climbs 15.4% Ahead of Pipeline Q2 Updates

Mar 25, 2026 Yahoo Finance

A Look At Summit Therapeutics (SMMT) Valuation After Recent Share Price Strength

Jan 7, 2026 Yahoo Finance

Citi Asserts Buy Rating on Summit Therapeutics Inc. (SMMT) on Pipeline Development

Dec 11, 2025 Yahoo Finance

A Look At Summit Therapeutics (SMMT) Valuation After New Ivonescimab Phase III Data And FDA BLA Filing

Mar 28, 2026 Yahoo Finance

Encouraging Guidance on Clinical Program Makes Summit Therapeutics (SMMT) Look Attractive

Jan 28, 2026 Yahoo Finance

Summit Therapeutics (SMMT) Is Up 6.9% After Phase III Ivonescimab Data And FDA Filing - What's Changed

Mar 27, 2026 Yahoo Finance

Summit Therapeutics (SMMT) Is Up 7.6% After Steep Losses And New US$102 Million Shelf Registration - Has The Bull Case Changed?